Which trial do we need? Comparison of 7 versus 14 days of antibiotic therapy for ventilator-associated pneumonia due to highly resistant gram-negative bacteria

被引：1
|
作者：
Tleyjeh, Imad M. [1 ,2 ,3 ,4 ,5 ]
机构：
[1] King Fahad Med City, Dept Med Specialties, Infect Dis Sect, Riyadh, Saudi Arabia
[2] Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia
[3] Mayo Clin, Coll Med & Sci, Div Publ Hlth Infect Dis & Occupat Med, Rochester, MN USA
[4] Mayo Clin, Coll Med & Sci, Div Epidemiol, Rochester, MN USA
[5] King Fahd Med City, Sect Infect Dis, POB 59046, Riyadh 11525, Saudi Arabia
来源：
CLINICAL MICROBIOLOGY AND INFECTION | 2023年 / 29卷 / 09期
关键词：
Drug resistance; Gram-negative bacteria; Pneumonia; Short-course therapy; Ventilator; Trial design considerations; INFECTIOUS-DISEASES SOCIETY; DURATION; AMERICA;
D O I：
10.1016/j.cmi.2023.04.018
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：1114 / 1116
页数：3
相关论文
共 50 条
  • [1] Which trial do we need? One or two antimicrobials with anti-pseudomonal activity for the empirical treatment of ventilator-associated pneumonia due to Gram-negative bacteria
    Yusuf, Erlangga
    Zavascki, Alexandre P.
    Endeman, Henrik
    Kalil, Andre C.
    CLINICAL MICROBIOLOGY AND INFECTION, 2023, 29 (11) : 1364 - 1366
  • [2] Evaluating antibiotic therapy for ventilator-associated pneumonia caused by gram-negative bacilli
    Malhotra, Raj
    Horng, Helen
    Bonne, Stephanie
    Sifri, Ziad
    Glass, Nina E.
    SURGERY OPEN SCIENCE, 2023, 16 : 64 - 67
  • [3] Management of ventilator-associated pneumonia (VAP) caused by resistant gram-negative bacteria: which is the best strategy to treat?
    Sarda, Cristina
    Fazal, Farhan
    Rello, Jordi
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2019, 13 (08) : 787 - 798
  • [4] Treatment of ventilator-associated pneumonia (VAP) caused by highly resistant gram-negative bacteria with local instillation of colistin
    Marino, WD
    Hrachian, HH
    Chkrebtii, N
    Komorowski, AW
    Gunturu, SD
    Corpuz, MO
    CHEST, 2003, 124 (04) : 79S - 80S
  • [5] CLINICAL OUTCOMES ASSOCIATED WITH ADJUNCTIVE AEROSOLIZED ANTIBIOTIC THERAPY IN GRAM-NEGATIVE VENTILATOR-ASSOCIATED PNEUMONIA
    Sawyer, Amber
    Arnold, Heather
    Reichley, Richard
    Micek, Scott
    Kollef, Marin
    CRITICAL CARE MEDICINE, 2010, 38 (12) : U178 - U178
  • [6] Use of direct Etest in the management of ventilator-associated pneumonia due to resistant Gram-negative pathogens
    David Partridge
    Lorcan Sheppard
    Tom Darton
    Robert Townsend
    Critical Care, 12 (Suppl 5):
  • [7] Meropenem by continuous versus intermittent infusion in ventilator-associated pneumonia due to gram-negative bacilli
    Lorente, L
    Lorenzo, L
    Martín, MM
    Jiménez, A
    Mora, ML
    ANNALS OF PHARMACOTHERAPY, 2006, 40 (02) : 219 - 223
  • [8] Rotation of antimicrobial therapy in the intensive care unit: impact on incidence of ventilator-associated pneumonia caused by antibiotic-resistant Gram-negative bacteria
    E. Raineri
    L. Crema
    S. Dal Zoppo
    A. Acquarolo
    A. Pan
    G. Carnevale
    F. Albertario
    A. Candiani
    European Journal of Clinical Microbiology & Infectious Diseases, 2010, 29 : 1015 - 1024
  • [9] Rotation of antimicrobial therapy in the intensive care unit: impact on incidence of ventilator-associated pneumonia caused by antibiotic-resistant Gram-negative bacteria
    Raineri, E.
    Crema, L.
    Dal Zoppo, S.
    Acquarolo, A.
    Pan, A.
    Carnevale, G.
    Albertario, F.
    Candiani, A.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2010, 29 (08) : 1015 - 1024
  • [10] Nebulized colistin for treatment of ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: we still need to straighten out the dose!
    Honore, Patrick M.
    Jacobs, Rita
    Hendrickx, Inne
    De Waele, Elisabeth
    De Regt, Jouke
    Spapen, Herbert D.
    CRITICAL CARE, 2015, 19
12345